Characteristic | Statin prescription | Unadjusteda | Adjustedb | |||
---|---|---|---|---|---|---|
 | Deviates from guidelines | Adheres with guidelines | OR | p-value | OR | p-value |
 | N (%) | N (%) | (95% CI) |  | (95% CI) |  |
Age group (years) | ||||||
  35–44 | 5,157 (10.75) | 42,832 (89.25) | reference |  | referencec |  |
  45–54 | 14,595 (19.42) | 60,548 (80.58) | 2.00 |  < 0.001 | 1.73 |  < 0.001 |
(1.94–2.07) | (1.65–1.82) | |||||
  55–64 | 24,799 (32.06) | 52,549 (67.94) | 3.92 |  < 0.001 | 3.01 |  < 0.001 |
(3.79–4.05) | (2.87–3.15) | |||||
  65–75 | 25,823 (41.01) | 37,146 (58.99) | 5.77 |  < 0.001 | 3.84 |  < 0.001 |
(5.59–5.97) | (3.66–4.02) | |||||
Sex | ||||||
  Male | 38,648 (34.28) | 74,097 (65.72) | 1.96 |  < 0.001 | 1.74 |  < 0.001 |
(1.92–1.99) | (1.70–1.79) | |||||
  Female | 31,726 (21.05) | 118,978 (78.95) | reference | – | reference | – |
Socioeconomic deprivation quintiles | ||||||
  Q1 (least) | 7,560 (23.43) | 24,709 (76.57) | reference | – | reference | – |
  Q2 | 8,436 (23.19) | 27,946 (76.81) | 0.99 | 0.456 | 1.01 | 0.684 |
(0.95–1.02) | (0.97–1.05) | |||||
  Q3 | 7,130 (23.59) | 23,089 (76.41) | 1.01 | 0.624 | 1.01 | 0.543 |
(0.97–1.05) | (0.97–1.05) | |||||
  Q4 | 6,131 (25.91) | 17,531 (74.09) | 1.14 |  < 0.001 | 1.10 |  < 0.001 |
(1.10–1.19) | (1.05–1.14) | |||||
  Q5 (most) | 6,183 (28.43) | 15,563 (71.57) | 1.30 |  < 0.001 | 1.21 |  < 0.001 |
(1.25–1.35) | (1.16–1.26) | |||||
Diabetes | ||||||
  Yes | 14,383 (43.10) | 18,989 (56.90) | 3.23 |  < 0.001 | 2.25 |  < 0.001 |
(3.15–3.32) | (2.19–2.31) | |||||
  No | 21,057 (18.99) | 89,849 (81.01) | reference | – | reference | – |
Hypertension | ||||||
  Yes | 15,335 (35.08) | 28,382 (64.92) | 2.16 |  < 0.001 | 1.27 |  < 0.001 |
(2.11–2.22) | (1.24–1.31) | |||||
  No | 20,105 (19.99) | 80,456 (80.01) | reference | – | reference | – |